Global Proton Pump Inhibitors (ppis) Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	199 Pages	TechNavio	January, 2025	INF19520312

Best Price Guarantee
Price	from $2,500
Length	199 Pages
Publisher	TechNavio
Published Date	January, 2025
SKU	INF19520312

Proton Pump Inhibitors (PPIs) Market 2025-2029

The proton pump inhibitors (PPIs) market is forecasted to grow by USD 819.5 mn during 2024-2029, accelerating at a CAGR of 4.7% during the forecast period. The report on the proton pump inhibitors (PPIs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reformulation of drugs, growth in prescription rate, and strong prevalence of gastroesophageal reflux disease.

Technavio's proton pump inhibitors (PPIs) market is segmented as below:

By Product

OTC PPIs
Prescription PPIs

By Route Of Administration

Oral
Injectable

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing geriatric population as one of the prime reasons driving the proton pump inhibitors (PPIs) market growth during the next few years. Also, rising prevalence of obesity and personalized ppi therapy will lead to sizable demand in the market.

The report on the proton pump inhibitors (PPIs) market covers the following areas:

Proton Pump Inhibitors (PPIs) Market sizing
Proton Pump Inhibitors (PPIs) Market forecast
Proton Pump Inhibitors (PPIs) Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proton pump inhibitors (PPIs) market vendors that include Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Inc., Perrigo Co. Plc, Pfizer Inc., RedHill Biopharma Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., The Procter and Gamble Co., and Zydus Lifesciences Ltd.. Also, the proton pump inhibitors (PPIs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Proton Pump Inhibitors (PPIs) Market 2019 - 2023; Historic Market Size - Data Table on Global Proton Pump Inhibitors (PPIs) Market 2019 - 2023 ($ million); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ million); 5.3 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 The AI impact on Global Proton Pump Inhibitors (PPIs) Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 OTC PPIs - Market size and forecast 2024-2029; Chart on OTC PPIs - Market size and forecast 2024-2029 ($ million); Data Table on OTC PPIs - Market size and forecast 2024-2029 ($ million); Chart on OTC PPIs - Year-over-year growth 2024-2029 (%); Data Table on OTC PPIs - Year-over-year growth 2024-2029 (%); 8.4 Prescription PPIs - Market size and forecast 2024-2029; Chart on Prescription PPIs - Market size and forecast 2024-2029 ($ million); Data Table on Prescription PPIs - Market size and forecast 2024-2029 ($ million); Chart on Prescription PPIs - Year-over-year growth 2024-2029 (%); Data Table on Prescription PPIs - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Route of Administration: 9.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 9.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 9.3 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ million); Data Table on Oral - Market size and forecast 2024-2029 ($ million); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 9.4 Injectable - Market size and forecast 2024-2029; Chart on Injectable - Market size and forecast 2024-2029 ($ million); Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Chart on Injectable - Year-over-year growth 2024-2029 (%); Data Table on Injectable - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.9 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.10 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.11 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.14 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.15 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 11.16 UAE - Market size and forecast 2024-2029; Chart on UAE - Market size and forecast 2024-2029 ($ million); Data Table on UAE - Market size and forecast 2024-2029 ($ million); Chart on UAE - Year-over-year growth 2024-2029 (%); Data Table on UAE - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 14.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 14.6 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; SWOT; 14.7 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; SWOT; 14.8 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 14.9 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; SWOT; 14.10 Eisai Co. Ltd.; Eisai Co. Ltd. - Overview; Eisai Co. Ltd. - Business segments; Eisai Co. Ltd. - Key offerings; Eisai Co. Ltd. - Segment focus; SWOT; 14.11 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; SWOT; 14.12 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 14.13 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.14 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 14.15 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; SWOT; 14.16 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT; 14.17 The Procter and Gamble Co.; The Procter and Gamble Co. - Overview; The Procter and Gamble Co. - Business segments; The Procter and Gamble Co. - Key news; The Procter and Gamble Co. - Key offerings; The Procter and Gamble Co. - Segment focus; SWOT; 14.18 Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd. - Overview; Zydus Lifesciences Ltd. - Business segments; Zydus Lifesciences Ltd. - Key news; Zydus Lifesciences Ltd. - Key offerings; Zydus Lifesciences Ltd. - Segment focus; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Proton Pump Inhibitors (PPIs) Market 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Product - Market share 2024-2029 (%); Exhibits37: Data Table on Product - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Product; Exhibits39: Data Table on Comparison by Product; Exhibits40: Chart on OTC PPIs - Market size and forecast 2024-2029 ($ million); Exhibits41: Data Table on OTC PPIs - Market size and forecast 2024-2029 ($ million); Exhibits42: Chart on OTC PPIs - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on OTC PPIs - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Prescription PPIs - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Prescription PPIs - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Prescription PPIs - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Prescription PPIs - Year-over-year growth 2024-2029 (%); Exhibits48: Market opportunity by Product ($ million); Exhibits49: Data Table on Market opportunity by Product ($ million); Exhibits50: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits51: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits52: Chart on Comparison by Route of Administration; Exhibits53: Data Table on Comparison by Route of Administration; Exhibits54: Chart on Oral - Market size and forecast 2024-2029 ($ million); Exhibits55: Data Table on Oral - Market size and forecast 2024-2029 ($ million); Exhibits56: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits59: Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits60: Chart on Injectable - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Injectable - Year-over-year growth 2024-2029 (%); Exhibits62: Market opportunity by Route of Administration ($ million); Exhibits63: Data Table on Market opportunity by Route of Administration ($ million); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits66: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits70: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits71: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits74: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits75: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits77: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits78: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits79: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits86: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits87: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on UAE - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on UAE - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on UAE - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on UAE - Year-over-year growth 2024-2029 (%); Exhibits125: Market opportunity By Geographical Landscape ($ million); Exhibits126: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits127: Impact of drivers and challenges in 2024 and 2029; Exhibits128: Overview on criticality of inputs and factors of differentiation; Exhibits129: Overview on factors of disruption; Exhibits130: Impact of key risks on business; Exhibits131: Companies covered; Exhibits132: Company ranking index; Exhibits133: Matrix on companies position and classification; Exhibits134: Amgen Inc. - Overview; Exhibits135: Amgen Inc. - Product / Service; Exhibits136: Amgen Inc. - Key news; Exhibits137: Amgen Inc. - Key offerings; Exhibits138: SWOT; Exhibits139: AstraZeneca Plc - Overview; Exhibits140: AstraZeneca Plc - Product / Service; Exhibits141: AstraZeneca Plc - Key news; Exhibits142: AstraZeneca Plc - Key offerings; Exhibits143: SWOT; Exhibits144: Aurobindo Pharma Ltd. - Overview; Exhibits145: Aurobindo Pharma Ltd. - Product / Service; Exhibits146: Aurobindo Pharma Ltd. - Key offerings; Exhibits147: SWOT; Exhibits148: Bausch Health Companies Inc. - Overview; Exhibits149: Bausch Health Companies Inc. - Business segments; Exhibits150: Bausch Health Companies Inc. - Key news; Exhibits151: Bausch Health Companies Inc. - Key offerings; Exhibits152: Bausch Health Companies Inc. - Segment focus; Exhibits153: SWOT; Exhibits154: Bayer AG - Overview; Exhibits155: Bayer AG - Business segments; Exhibits156: Bayer AG - Key news; Exhibits157: Bayer AG - Key offerings; Exhibits158: Bayer AG - Segment focus; Exhibits159: SWOT; Exhibits160: Dr Reddys Laboratories Ltd. - Overview; Exhibits161: Dr Reddys Laboratories Ltd. - Business segments; Exhibits162: Dr Reddys Laboratories Ltd. - Key news; Exhibits163: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits164: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits165: SWOT; Exhibits166: Eisai Co. Ltd. - Overview; Exhibits167: Eisai Co. Ltd. - Business segments; Exhibits168: Eisai Co. Ltd. - Key offerings; Exhibits169: Eisai Co. Ltd. - Segment focus; Exhibits170: SWOT; Exhibits171: Eli Lilly and Co. - Overview; Exhibits172: Eli Lilly and Co. - Product / Service; Exhibits173: Eli Lilly and Co. - Key offerings; Exhibits174: SWOT; Exhibits175: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits176: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits177: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits178: SWOT; Exhibits179: Pfizer Inc. - Overview; Exhibits180: Pfizer Inc. - Product / Service; Exhibits181: Pfizer Inc. - Key news; Exhibits182: Pfizer Inc. - Key offerings; Exhibits183: SWOT; Exhibits184: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits185: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits186: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits187: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits188: SWOT; Exhibits189: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits190: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits191: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits192: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits193: SWOT; Exhibits194: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits195: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits196: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits197: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits198: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits199: SWOT; Exhibits200: The Procter and Gamble Co. - Overview; Exhibits201: The Procter and Gamble Co. - Business segments; Exhibits202: The Procter and Gamble Co. - Key news; Exhibits203: The Procter and Gamble Co. - Key offerings; Exhibits204: The Procter and Gamble Co. - Segment focus; Exhibits205: SWOT; Exhibits206: Zydus Lifesciences Ltd. - Overview; Exhibits207: Zydus Lifesciences Ltd. - Business segments; Exhibits208: Zydus Lifesciences Ltd. - Key news; Exhibits209: Zydus Lifesciences Ltd. - Key offerings; Exhibits210: Zydus Lifesciences Ltd. - Segment focus; Exhibits211: SWOT; Exhibits212: Inclusions checklist; Exhibits213: Exclusions checklist; Exhibits214: Currency conversion rates for US$; Exhibits215: Research methodology; Exhibits216: Information sources; Exhibits217: Data validation; Exhibits218: Validation techniques employed for market sizing; Exhibits219: Data synthesis; Exhibits220: 360 degree market analysis; Exhibits221: List of abbreviations